Gut microbiota and nonalcoholic fatty liver disease

Recent evidence has linked obesity and the metabolic syndrome with gut dysbiota. The precise mechanisms underlying that association are not entirely understood; however, microbiota can enhance the extraction of energy f...

SALLuting a new biomarker in hepatocellular carcinoma

Percutaneous shunt reduction for the management of TIPS-induced acute liver decompensation: A follow-up study

Background and rationale for the study. The purpose of this study was to assess the technical and clinical outcomes of transjugular intrahepatic portosystemic shunt (TIPS) reduction for the management of TIPS-induced ac...

Elafibranor for the treatment of NAFLD: One pill, two molecular targets and multiple effects in a complex phenotype.

The Annals of Hepatology welcomes the Canadian Association for the Study of the Liver (CASL)